Cargando…
Harms and benefits of sodium-glucose co-transporter 2 inhibitors
Sodium-glucose co-transporter 2 inhibitors are oral glucose-lowering drugs that increase the urinary excretion of glucose. In patients with type 2 diabetes and cardiovascular disease they reduce all-cause mortality, cardiac mortality, rates of hospitalisation for heart failure and the progression of...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
NPS MedicineWise
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572185/ https://www.ncbi.nlm.nih.gov/pubmed/33093744 http://dx.doi.org/10.18773/austprescr.2020.049 |